accountThe use of radioactive iodine to treat thyroid cancer increased 40 percent from 1990 to 2008 even though the risks may outweigh the benefits for some patients, particularly those with early-stage tumors, researchers said.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Radioactive Iodine Risks May Outweigh Benefit for Some Tumors, Study Finds
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account